Curley Joanne has filed 5 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 17600 shares of Vistagen Therapeutics, Inc. ($VTGN) on September 09, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Curley Joanne | Director | A | Non-Qualified Stock Option (right to buy) | 17600 | $0.00 | 17,600.0000 | 29,157,733 | 9999.99% | 0.06% |
| Sept. 6, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Curley Joanne | Not found | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 19,354,500 | 9999.99% | 0.07% |
| March 4, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Curley Joanne | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 21, 2023 | Vera Therapeutics, Inc. | $VERA | Curley Joanne | Chief Development Officer | S | Class A Common Stock | 1490 | $16.66 | 26,962.0000 | 0 | 5.24% | 0.00% |
| Feb. 15, 2023 | Vera Therapeutics, Inc. | $VERA | Curley Joanne | Chief Development Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |